[1]冯欢欢.骨质疏松症中医理论研究的文献计量学分析[J].医学信息,2022,35(16):28-32.[doi:10.3969/j.issn.1006-1959.2022.16.006]
　FENG Huan-huan.Bibliometric Analysis of TCM Theoretical Research on Osteoporosis[J].Journal of Medical Information,2022,35(16):28-32.[doi:10.3969/j.issn.1006-1959.2022.16.006]
点击复制

骨质疏松症中医理论研究的文献计量学分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年16期
页码:
28-32
栏目:
医学数据科学
出版日期:
2022-08-15

文章信息/Info

Title:
Bibliometric Analysis of TCM Theoretical Research on Osteoporosis
文章编号:
1006-1959（2022）16-0028-05
作者:
冯欢欢
（太仓市中医医院骨伤科，江苏 太仓 215400）
Author(s):
FENG Huan-huan
(Department of Orthopedics and Traumatology,Taicang Hospital of Traditional Chinese Medicine,Taicang 215400,Jiangsu,China)
关键词:
骨质疏松症; 中医理论; 藏象学说; 络病学说; 血瘀理论
Keywords:
Osteoporosis; The Theory of Chinese medicine; Zang-fu; The theory of collateral diseases; The theory of blood stasis
分类号:
R228
DOI:
10.3969/j.issn.1006-1959.2022.16.006
文献标志码:
A
摘要:
目的 通过文献计量学方法分析骨质疏松症的中医理论研究情况。方法 计算机检索中国知识资源总库、万方数据学术论文总库、维普中文科技期刊全文数据库中有关骨质疏松症的中医理论研究文献，检索时间为建库至2020年12月31日，记录文献的基本信息、文献内容，包括题目、发表年份、发表杂志、基金项目支持情况、研究对象、研究内容等。结果 共纳入71篇文献，最早文献发表于1998年，1998-2020年骨质疏松中医理论研究领域平均每年发文3篇，其中以骨质疏松为研究对象的文献最多，占56.34%（40篇），其次为绝经后骨质疏松，占23.94%（17篇）；71篇文献中，国家级基金项目18项，省级基金项目8项，市级基金项目1项；71篇文献从7种中医学说理论进行研究，分别为标本理论、藏象学说、阴阳学说、气血理论、络病学说、血瘀理论、八卦理论，其中脏腑学说的文献最多，占70.42%（50篇），其次为络病学说，占12.68%（9篇）；藏象学说50篇文献中，从肾论治最多，占比92.00%。结论 藏象学说是中医研究骨质疏松症的主要方向，其次是络病学说、肾虚、血瘀等。
Abstract:
Objective To analyze the theoretical research of osteoporosis in traditional Chinese medicine by bibliometrics.Methods A computer-based retrieval of TCM theoretical research literature on osteoporosis in China Knowledge Resource Database, Wanfang Data Academic Paper Database, and VIP Chinese Science and Technology Journal Full-text Database was conducted. The retrieval time was from the establishment of the database to December 31, 2020. The basic information and literature content of the literature were recorded, including title, year of publication, published journal, fund project support, research object, research content, etc.Results The earliest literatures included in the literature search were published in 1998. From 1998 to 2020, a total of 71 literatures on traditional Chinese medicine theoretical research on osteoporosis were retrieved, with an average of 3 papers per year. Most of the included literatures took osteoporosis as the research object, accounting for 56.34% (40 articles), followed by postmenopausal osteoporosis, accounting for 23.94% (17 articles). Among the 71 papers, there were 18 national fund projects, 8 provincial fund projects, and 1 municipal fund project. The 71 literatures were studied from 7 theories of traditional Chinese medicine, namely the theory of specimens, the theory of Zang-fu, the theory of Yin and Yang, the theory of Qi and blood, the theory of collateral diseases, the theory of blood stasis, and the theory of gossip. Among them, the Zang-fu theory had the most literature, accounting for 70.42% (50 articles), followed by the collateral disease theory, accounting for 12.68% (9 articles). Among the 50 articles on Tibetan image theory, the treatment from kidney was the most, accounting for 92.00%.Conclusion The theory of Zang-fu is the main direction of the study of osteoporosis, followed by collateral disease, kidney deficiency and blood stasis account for a high proportion.

参考文献/References:

[1]中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南（2017）[J].中华骨质疏松和骨矿盐疾病杂志,2017,10(5):413-443.[2]Feng H,Gong Z,Liang G,et al.Gumi Bao decoction regulates bone metabolism-related mRNA expression in glucocorticoidinduced osteoporosis in rats[J].Ann Palliat Med,2020,9(5):3213-3221.[3]汤志利,欧阳建江,徐鑫.补肾活血汤治疗绝经后骨质疏松症的临床效果评价[J].江西医药,2021,56(6):854-855.[4]李家德,钟永翔,陈永志,等.腰痛方颗粒联合抗骨质疏松药物治疗肝肾亏虚型老年性骨质疏松德效果[J].医学信息,2020,33(22):163-166.[5]赵海玲,周宗波,李建强,等.加味补肾活血汤联合中药熏蒸治疗骨质疏松性椎体压缩性骨折术后患者的临床观察[J].中国实验方剂学杂志,2019,25(8):95-100.[6]毛国庆,陈世洲,孙玉明,等.温肾健骨方治疗阳虚质骨质疏松症50例临床研究[J].中华中医药杂志,2020,35(6):3266-3269.[7]巩彦龙,宋敏,董万涛,等.固本增骨方治疗老年原发性骨质疏松的随机对照临床试验研究[J].中国骨质疏松杂志,2020,26(5):676-679,701.[8]顾伏龙,周斌,姜江,等.补肾健脾壮骨方治疗脾肾两虚型原发性骨质疏松症的临床研究[J].中药材,2019,42(1):216-218.[9]柴生颋,谢平金,方鸿星,等.补肾中药骨康方治疗肾阳虚型绝经后骨质疏松症疗效及对E2、 OPG及IGF-1影响[J].辽宁中医药大学学报,2018,20(7):170-173.[10]邱敏丽,谢雅,王晓红,等.骨质疏松症患者实践指南[J].中华内科杂志,2020,59(12):953-959.[11]肖勇洪,彭江云,李兆福,等.基于“阳化气,阴成形”理论探讨骨质疏松症的中医证治[J].中国中医基础医学杂志,2020,26(3):401-403.[12]张惜燕.补肾健脾活血法防治骨质疏松症的分子机制研究[D].咸阳:陕西中医药大学,2016.[13]葛继荣,王和鸣,郑洪新,等.中医药防治原发性骨质疏松症专家共识（2020）[J].中国骨质疏松杂志,2020,26(12):1717-1725.[14]陈巨鹏,黄国淳,严晓莺,等.从疏解“肝郁”谈绝经后骨质疏松症的辨治体会[J].中医药导报,2020,26(15):179-181.[15]郑秀霞,林应华,黄雯晖,等.原发性骨质疏松症中医辨证分型研究[J].中医临床研究,2019,11(25):50-52.[16]赵振霞,赵振敏,田玉慧,等.中医辨治骨质疏松症体会[J].河南中医,2015,35(7):1480-1482.[17]史馨钰,任艳玲.基于“命门学说”与“阴阳互济”探讨绝经后骨质疏松症的防治[J].中国医药导报,2019,16(25):110-113.[18]陈元川,李志强,庞坚,等.浅析石氏气血理论在骨质疏松防治中的指导意义[J].上海中医药大学学报,2018,32(1):8-10.[19]苑文超,马勇,闵文,等.黄桂成运用络病理论治疗骨质疏松经验[J].山东中医杂志,2018,37(4):310-312.[20]郑显达,陈凯.陈海鹏骨坚方治疗骨质疏松症临证经验窥探[J].风湿病与关节炎,2018,7(4):54-56.[21]段亚威,柴昊,安一方,等.从瘀论治原发性骨质疏松症[J].风湿病与关节炎,2021,10(2):55-58.[22]沈耿杨,杨志东,任辉,等.从坎卦角度探讨激素性骨质疏松症的病机及治法[J].四川中医,2015,33(8):32-34.

相似文献/References:

[1]汪钦生,邵 敏,姜 涛.绝经后妇女中骨质疏松患者血清钙磷、骨代谢指标与BMD的关系[J].医学信息,2019,32(04):1.[doi:10.3969/j.issn.1006-1959.2019.04.001]
　WANG Qin-sheng,SHAO Min,JIANG Tao.Relationship between Serum Calcium,Phosphorus and Bone Metabolism Markers and BMD in Postmenopausal Women with Osteoporosis[J].Journal of Medical Information,2019,32(16):1.[doi:10.3969/j.issn.1006-1959.2019.04.001]
[2]李 红,孔令泉,吴凯南.乳腺癌相关骨质疏松症的发病机制及防治[J].医学信息,2020,33(07):36.[doi:10.3969/j.issn.1006-1959.2020.07.012]
　LI Hong,KONG Ling-quan,WU Kai-nan.Pathogenesis and Prevention of Breast Cancer Associated Osteoporosis[J].Journal of Medical Information,2020,33(16):36.[doi:10.3969/j.issn.1006-1959.2020.07.012]
[3]刘 纳,李玉兰,许明芳,等.2型糖尿病临床期肾病与骨密度及骨代谢标记物的相关性研究[J].医学信息,2020,33(08):70.[doi:10.3969/j.issn.1006-1959.2020.08.023]
　LIU Na,LI Yu-lan,XU Ming-fang,et al.Study on the Relationship Between Bone Mineral Density and Bone Metabolism Markers in Stage IV Nephropathy of Type 2 Diabetes Mellitus[J].Journal of Medical Information,2020,33(16):70.[doi:10.3969/j.issn.1006-1959.2020.08.023]
[4]石耀武,陶宝琛,张宏蕾.西安地区骨质疏松症的影响因素及中医证型分布[J].医学信息,2020,33(11):136.[doi:10.3969/j.issn.1006-1959.2020.11.043]
　SHI Yao-wu,TAO Bao-chen,ZHANG Hong-lei.Influencing Factors of Osteoporosis in Xi’an and Distribution of TCM Syndromes[J].Journal of Medical Information,2020,33(16):136.[doi:10.3969/j.issn.1006-1959.2020.11.043]
[5]张 宁,夏晓黎,王亚锋,等.慢性阻塞性肺疾病合并骨质疏松症危险因素的Meta分析[J].医学信息,2022,35(24):108.[doi:10.3969/j.issn.1006-1959.2022.24.020]
　ZHANG Ning,XIA Xiao-li,WANG Ya-feng,et al.Meta-analysis of Risk Factors for Chronic Obstructive Pulmonary Disease Complicated with Osteoporosis[J].Journal of Medical Information,2022,35(16):108.[doi:10.3969/j.issn.1006-1959.2022.24.020]
[6]米尔阿地力·麦麦提依明,阿卜杜萨拉木·亚克甫,沈志敏.骨质疏松对全膝关节置换术后康复的影响[J].医学信息,2021,34(09):99.[doi:10.3969/j.issn.1006-1959.2021.09.026]
　Mieradili·Maimaitiyiming,Abudusalamu·Yakepu,SHEN Zhi-min.Effect of Osteoporosis on Rehabilitation After Total Knee Arthroplasty[J].Journal of Medical Information,2021,34(16):99.[doi:10.3969/j.issn.1006-1959.2021.09.026]
[7]周奕良,毛国庆.基于网络药理学和分子对接技术探讨淫羊藿苷治疗骨质疏松症的作用机制[J].医学信息,2023,36(05):29.[doi:10.3969/j.issn.1006-1959.2023.05.005]
　ZHOU Yi-liang,MAO Guo-qing.The Mechanism of Icariin in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking Technology[J].Journal of Medical Information,2023,36(16):29.[doi:10.3969/j.issn.1006-1959.2023.05.005]
[8]李泽芹.降钙素联合阿仑膦酸盐治疗原发性骨质疏松症有效性评价[J].医学信息,2021,34(17):154.[doi:10.3969/j.issn.1006-1959.2021.17.041]
　LI Ze-qin.Evaluation of the Effectiveness of Calcitonin Combined with Alendronate Sodium in the Treatment of Primary Osteoporosis[J].Journal of Medical Information,2021,34(16):154.[doi:10.3969/j.issn.1006-1959.2021.17.041]
[9]王彦金,周英杰,黄 勇.单、双侧椎弓根入路经皮椎体成形术治疗骨质疏松型椎体压缩骨折的对比研究[J].医学信息,2023,36(08):127.[doi:10.3969/j.issn.1006-1959.2023.08.027]
　WANG Yan-jin,ZHOU Ying-jie,HUANG Yong,et al.Comparative Study of Unilateral and Bilateral Pedicle Approach Percutaneous Vertebroplasty in the Treatment of Osteoporotic Vertebral Compression Fractures[J].Journal of Medical Information,2023,36(16):127.[doi:10.3969/j.issn.1006-1959.2023.08.027]
[10]朱道信,罗志环,陈少健,等.唑来膦酸联合骨化三醇对骨质疏松症患者骨密度及骨代谢相关指标的影响[J].医学信息,2021,34(23):162.[doi:10.3969/j.issn.1006-1959.2021.23.049]
　ZHU Dao-xin,LUO Zhi-huan,CHEN Shao-jian,et al.Effect of Zoledronic Acid Combined with Calcitriol on Bone Mineral Density and Bone Metabolism in Patients with Osteoporosis[J].Journal of Medical Information,2021,34(16):162.[doi:10.3969/j.issn.1006-1959.2021.23.049]

更新日期/Last Update: 1900-01-01